Leptin–VEGF crosstalk in excess body mass and related disorders: A systematic review
Obesity Reviews · 2023
DOI: 10.1111/obr.13575 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Obesity Reviews, 2023. Verfasst von Damian Skrypnik und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics, Poznań University of Medical Sciences, Poznań, Poland. Hauptthemen laut MEDLINE: Leptin, Vascular Endothelial Growth Factor A. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 146 Literaturangaben. Gefördert von: Narodowym Centrum Nauki, Narodowe Centrum Nauki.
Abstract (Originalsprache)
By 2030, it is expected that a billion people will have suffer from obesity. Adipose tissue synthesizes leptin, an adipokine that affects cardiovascular risk. Leptin intensifies the synthesis of vascular endothelial growth factor (VEGF). Our study reviews recent reports on leptin–VEGF crosstalk in obesity and related disorders. PubMed, Web of Science, Scopus, and Google Scholar were searched. One hundred and one articles involving human, animal, and in vitro research were included. In vitro studies show the crucial role of interaction between endothelial cells and adipocytes and hypoxia as a factor that intensifies leptin's effects on VEGF. Leptin–VEGF crosstalk promotes the progression of cancer. The animal research reveal that a high‐fat diet enhances leptin and VEGF crosstalk. Genetic and epigenetic mechanisms and procreator‐offspring programming may be involved in leptin–VEGF crosstalk. Some female‐specific characteristics of leptin–VEGF relation in obesity were observed. The human studies have shown that increased leptin and VEGF synthesis and leptin–VEGF crosstalk are factors linking obesity with elevated cardiovascular risk. The studies of the last 10 years documented a range of significant aspects of leptin–VEGF crosstalk specific for obesity and related disorders, shedding new light on the link between obesity and increased cardiovascular risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics, Poznań University of Medical Sciences, Poznań, Poland.
- Department of Human Nutrition and Dietetics, Poznań University of Life Sciences, Poznań, Poland.
ORCID-Profile: Damian Skrypnik, Katarzyna Skrypnik, Joanna Suliburska, Paweł Bogdański
Förderung
- Narodowym Centrum Nauki
- Narodowe Centrum Nauki
Zitieren
APA
Skrypnik, D., Skrypnik, K., Suliburska, J., & Bogdański, P. (2023). Leptin–VEGF crosstalk in excess body mass and related disorders: A systematic review. Obesity Reviews. https://doi.org/10.1111/obr.13575
Vancouver
Skrypnik D, Skrypnik K, Suliburska J, Bogdański P. Leptin–VEGF crosstalk in excess body mass and related disorders: A systematic review. Obesity Reviews. 2023. doi:10.1111/obr.13575
BibTeX
@article{Skrypnik2023,
author = {Skrypnik, Damian and Skrypnik, Katarzyna and Suliburska, Joanna and Bogdański, Paweł},
title = {Leptin–VEGF crosstalk in excess body mass and related disorders: A systematic review},
journal = {Obesity Reviews},
year = {2023},
doi = {10.1111/obr.13575}
}
EUVIMED